P2Y2 receptor promotes cell invasion and metastasis in prostate cancer cells

British Journal of Cancer

Volumn 109, Issue 6, 2013, Pages 1666-1675

  Li, W H ^a,b   Qiu, Y ^a,b   Zhang, H Q ^a,b   Liu, Y ^a,b   You, J F ^a,b   Tian, X X ^a,b   Fang, W G ^a,b  

^a China   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CLAUDIN 1; COMPLEMENTARY DNA; INTERLEUKIN 8; MESSENGER RNA; PURINERGIC P2Y2 RECEPTOR; TRANSCRIPTION FACTOR SNAIL; UVOMORULIN;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DNA MICROARRAY; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GENE FUNCTION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CARCINOMA; REGULATORY MECHANISM; RNA INTERFERENCE;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROSTATIC NEOPLASMS; RECEPTORS, PURINERGIC P2Y2; RNA INTERFERENCE; TRANSFECTION;

EID: 84884594311     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.484     Document Type: Article

References (45)

1. Abbracchio MP, Burnstock G (1998) Purinergic signalling: Pathophysiological roles. Jpn J Pharmacol 78(2): 113-145.
2. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, Mcewan RN (1987) A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47(12): 3239-3245.
3. Bagchi S, Liao Z, Gonzalez FA, Chorna NE, Seye CI, Weisman GA, Erb L (2005) The P2Y2 nucleotide receptor interacts with alphav integrins to activate Go and induce cell migration. J Biol Chem 280(47): 39050-39057.
4. Chen L, He HY, Li HM, Zheng J, Heng WJ, You JF, Fang WG (2004) ERK1/2 and p38 pathways are required for P2Y receptor-mediated prostate cancer invasion. Cancer Lett 215(2): 239-247.
5. Chen Y, Corriden R, Inoue Y, Yip L, Hashiguchi N, Zinkernagel A, Nizet V, Insel PA, Junger WG (2006) ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors. Science 314(5806): 1792-1795.
6. Christiansen JJ, Rajasekaran AK (2006) Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res 66(17): 8319-8326.
7. Cunha GR, Hayward SW, Wang YZ, Ricke WA (2003) Role of the stromal microenvironment in carcinogenesis of the prostate. Int J Cancer 107(1): 1-10.
8. Davis FM, Azimi I, Faville RA, Peters AA, Jalink K, Putney Jr JW, Goodhill GJ, Thompson EW, Roberts-Thomson SJ, Monteith GR (2013) Induction of epithelial-mesenchymal transition (EMT) in breast cancer cells is calcium signal dependent. Oncogene; e-pub ahead of print 20 May 2013; doi:10.1038/onc.2013.187.
9. Davis FM, Kenny PA, Soo ET, Van Denderen BJ, Thompson EW, Cabot PJ, Parat MO, Roberts-Thomson SJ, Monteith GR (2011) Remodeling of purinergic receptor-mediated Ca2+ signaling as a consequence of EGFinduced epithelial-mesenchymal transition in breast cancer cells. PLoS One 6(8): E23464.
10. Davis FM, Peters AA, Grice DM, Cabot PJ, Parat MO, Roberts-Thomson SJ, Monteith GR (2012) Non-stimulated, agonist-stimulated and storeoperated Ca2+ influx in MDA-MB-468 breast cancer cells and the effect of EGF-induced EMT on calcium entry. PLoS One 7(5): E36923.
11. Di Virgilio F (2012) Purines, purinergic receptors, and cancer. Cancer Res 72(21): 5441-5447.
12. Fang WG, Pirnia F, Bang YJ, Myers CE, Trepel JB (1992) P2-purinergic receptor agonists inhibit the growth of androgen-independent prostate carcinoma cells. J Clin Invest 89(1): 191-196.
13. Hatanaka H, Takada S, Choi YL, Fujiwara S, Soda M, Enomoto M, Kurashina K, Watanabe H, Yamashita Y, Sugano K, Mano H (2007) Transforming activity of purinergic receptor P2Y, G-protein coupled, 2 revealed by retroviral expression screening. Biochem Biophys Res Commun 356(3): 723-726.
14. Hopfner M, Maaser K, Barthel B, Von Lampe B, Hanski C, Riecken EO, Zeitz M, Scherubl H (2001) Growth inhibition and apoptosis induced by P2Y2 receptors in human colorectal carcinoma cells: Involvement of intracellular calcium and cyclic adenosine monophosphate. Int J Colorectal Dis 16(3): 154-166.
15. Idzko M, Panther E, Bremer HC, Sorichter S, Luttmann W, Virchow Jr CJ, Di Virgilio F, Herouy Y, Norgauer J, Ferrari D (2003) Stimulation of P2 purinergic receptors induces the release of eosinophil cationic protein and interleukin-8 from human eosinophils. Br J Pharmacol 138(7): 1244-1250.
16. Inoue K, Slaton JW, Eve BY, Kim SJ, Perrotte P, Balbay MD, Yano S, Bar-Eli M, Radinsky R, Pettaway CA, Dinney CP (2000) Interleukin 8 expression regulates tumorigenicity and metastases in androgenindependent prostate cancer. Clin Cancer Res 6(5): 2104-2119.
17. Jaeger EB, Samant RS, Rinker-Schaeffer CW (2001) Metastasis suppression in prostate cancer. Cancer Metastasis Rev 20(3-4): 279-286.
18. Janssens R, Boeynaems JM (2001) Effects of extracellular nucleotides and nucleosides on prostate carcinoma cells. Br J Pharmacol 132(2): 536-546.
19. Jantaratnotai N, Mclarnon JG (2011) Calcium dependence of purinergic subtype P2Y(1) receptor modulation of C6 glioma cell migration. Neurosci Lett 497(2): 80-84.
20. Jelassi B, Chantome A, Alcaraz-Perez F, Baroja-Mazo A, Cayuela ML, Pelegrin P, Surprenant A, Roger S (2011) P2X(7) receptor activation enhances SK3 channels- and cystein cathepsin-dependent cancer cells invasiveness. Oncogene 30(18): 2108-2122.
21. Kukulski F, Ben Yebdri F, Lecka J, Kauffenstein G, Levesque SA, Martin-Satue M, Sevigny J (2009) Extracellular ATP and P2 receptors are required for IL-8 to induce neutrophil migration. Cytokine 46(2): 166-170.
22. Kunzli BM, Berberat PO, Giese T, Csizmadia E, Kaczmarek E, Baker C, Halaceli I, Buchler MW, Friess H, Robson SC (2007) Upregulation of CD39/NTPDases and P2 receptors in human pancreatic disease. Am J Physiol Gastrointest Liver Physiol 292(1): G223-G230.
23. Kunzli BM, Bernlochner MI, Rath S, Kaser S, Csizmadia E, Enjyoji K, Cowan P, D'apice A, Dwyer K, Rosenberg R, Perren A, Friess H, Maurer CA, Robson SC (2011) Impact of CD39 and purinergic signalling on the growth and metastasis of colorectal cancer. Purinergic Signal 7(2): 231-241.
24. Lin Y, Huang RC, Chen LP, Li SY, Shi Q, Jordan C, Huang RP (2004) Identification of interleukin-8 as estrogen receptor-regulated factor involved in breast cancer invasion and angiogenesis by protein arrays. Int J Cancer 109(4): 507-515.
25. Liu Y, Zheng J, Fang W, You J, Wang J, Cui X, Wu B (2001) Identification of metastasis associated gene G3BP by differential display in human cancer cell sublines with different metastatic potentials G3BP as highly expressed in non-metastatic. Chin Med J (Engl) 114(1): 35-38.
26. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(T)(-Delta Delta C) method. Methods 25(4): 402-408.
27. Maaser K, Hopfner M, Kap H, Sutter AP, Barthel B, Von Lampe B, Zeitz M, Scherubl H (2002) Extracellular nucleotides inhibit growth of human oesophageal cancer cells via P2Y(2)-receptors. Br J Cancer 86(4): 636-644.
28. Muscella A, Elia MG, Greco S, Storelli C, Marsigliante S (2003) Activation of P2Y2 receptor induces c-FOS protein through a pathway involving mitogen-activated protein kinases and phosphoinositide 3-kinases in HeLa cells. J Cell Physiol 195(2): 234-240.
29. Nylund G, Hultman L, Nordgren S, Delbro DS (2007) P2Y2- and P2Y4 purinergic receptors are over-expressed in human colon cancer. Auton Autacoid Pharmacol 27(2): 79-84.
30. Papatsoris AG, Papavassiliou AG (2001) Prostate cancer: Horizons in the development of novel anti-cancer strategies. Curr Med Chem Anticancer Agents 1(1): 47-70.
31. Pellegatti P, Raffaghello L, Bianchi G, Piccardi F, Pistoia V, Di Virgilio F (2008) Increased level of extracellular ATP at tumor sites: In vivo imaging with plasma membrane luciferase. PLoS One 3(7): E2599.
32. Rapaport E (1983) Treatment of human tumor cells with ADP or ATP yields arrest of growth in the S phase of the cell cycle. J Cell Physiol 114(3): 279-283.
33. Resnick MB, Konkin T, Routhier J, Sabo E, Pricolo VE (2005) Claudin-1 is a strong prognostic indicator in stage II colonic cancer: A tissue microarray study. Mod Pathol 18(4): 511-518.
34. Schafer R, Sedehizade F, Welte T, Reiser G (2003) ATP- and UTP-activated P2Y receptors differently regulate proliferation of human lung epithelial tumor cells. Am J Physiol Lung Cell Mol Physiol 285(2): L376-L385.
35. Shahzad MMK, Arevalo JM, Armaiz-Pena GN, Lu C, Stone RL, Moreno-Smith M, Nishimura M, Lee J-W, Jennings NB, Bottsford-Miller J, Vivas-Mejia P, Lutgendorf SK, Lopez-Berestein G, Bar-Eli M, Cole SW, Sood AK (2010) Stress Effects on FosB- and Interleukin-8 (IL8)-driven Ovarian Cancer Growth and Metastasis. J Biol Chem285(46): 35462-35470.
36. Soltoff SP (1998) Related adhesion focal tyrosine kinase and the epidermal growth factor receptor mediate the stimulation of mitogen-activated protein kinase by the G-protein-coupled P2Y2 receptor. Phorbol ester or [Ca2+]i elevation can substitute for receptor activation. J Biol Chem 273(36): 23110-23117.
37. Stagg J, Smyth MJ (2010) Extracellular adenosine triphosphate and adenosine in cancer. Oncogene 29(39): 5346-5358.
38. Steeg PS (2006) Tumor metastasis: Mechanistic insights and clinical challenges. Nat Med 12(8): 895-904.
39. Suh Y, Yoon CH, Kim RK, Lim EJ, Oh YS, Hwang SG, An S, Yoon G, Gye MC, Yi JM, Kim MJ, Lee SJ (2012) Claudin-1 induces epithelial-mesenchymal transition through activation of the c-Abl-ERK signaling pathway in human liver cells. Oncogene; e-pub ahead of print 3 June 2013; doi:10.1038/onc.2012.205.
40. Turksen K, Troy TC (2011) Junctions gone bad: Claudins and loss of the barrier in cancer. Biochim Biophys Acta 1816(1): 73-79.
41. Von Kugelgen I, Harden TK (2011) Molecular pharmacology, physiology, and structure of the P2Y receptors. Adv Pharmacol 61: 373-415.
42. White N, Ryten M, Clayton E, Butler P, Burnstock G (2005) P2Y purinergic receptors regulate the growth of human melanomas. Cancer Lett 224(1): 81-91.
43. Wu Y, Zhou BP (2010) TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and invasion. Br J Cancer 102(4): 639-644.
44. Zhang B, Kirov S, Snoddy J (2005) WebGestalt: An integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res 33(Web Server issue): W741-W748.
45. Zhang Y, Gong LH, Zhang HQ, Du Q, You JF, Tian XX, Fang WG (2010) Extracellular ATP enhances in vitro invasion of prostate cancer cells by activating Rho GTPase and upregulating MMPs expression. Cancer Lett 293(2): 189-197.